Neuralgia Treatments
Find Neuralgia Treatments
Medications for Neuralgia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Neuralgia.
Found 6 Approved Drugs for Neuralgia
Gabapentin
Brand Names
Gaba 300-EZS, Gabarone, Gralise, Neurontin, Relgaabi
Gabapentin
Brand Names
Gaba 300-EZS, Gabarone, Gralise, Neurontin, Relgaabi
Form: Tablet, Kit, Suspension, Capsule, Solution
Method of administration: Oral
FDA approval date: December 30, 1993
Classification: Anti-epileptic Agent
Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin capsules are indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )
Pregabalin
Brand Names
Lyrica, Pregablin
Pregabalin
Brand Names
Lyrica, Pregablin
Form: Tablet, Capsule, Solution
Method of administration: Oral
FDA approval date: December 30, 2004
LYRICA is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury LYRICA is indicated for:, Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ), Postherpetic neuralgia (PHN) ( 1 ), Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ), Fibromyalgia ( 1 ), Neuropathic pain associated with spinal cord injury ( 1 )
Carbamazepine
Brand Names
Carbamazepin, Carbatrol, Epitol, Equetro, Tegretol
Carbamazepine
Brand Names
Carbamazepin, Carbatrol, Epitol, Equetro, Tegretol
Form: Tablet, Suspension, Capsule
Method of administration: Oral
FDA approval date: March 11, 1968
Classification: Mood Stabilizer
Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine. Trigeminal Neuralgia Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.
Clonidine
Brand Names
Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3, Clonidine HCI, Clonidine Transdermal, Duraclon, Javadin, Nexiclon, ONYDA
Clonidine
Brand Names
Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3, Clonidine HCI, Clonidine Transdermal, Duraclon, Javadin, Nexiclon, ONYDA
Form: Patch, Injection, Tablet, Suspension, Solution
Method of administration: Epidural, Oral, Intravenous, Transdermal
FDA approval date: September 04, 1987
Classification: Central alpha-2 Adrenergic Agonist
Catapres‑TTS ® is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
Nucynta
Generic Name
Tapentadol
Nucynta
Generic Name
Tapentadol
Form: Tablet
Method of administration: Oral
FDA approval date: April 01, 2019
Classification: Opioid Agonist
NUCYNTA (tapentadol) tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults and pediatric patients aged 6 years and older with a body weight of at least 40kg. NUCYNTA tablets are an opioid analgesic indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults and pediatric patients aged 6 years and older with a body weight of at least 40 kg. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy, reserve opioid analgesics, including NUCYNTA tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ( 1.
Showing 1-5 of 6
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances